Características y resultados del tratamiento aplicado a los pacientes con cáncer de páncreas

Valón Costa, Oriol; Romaguera Barroso, Danilo; Rodríguez Fernández, Zenén; Romero García, Lázaro Ibrahim; Lubín García, Ana.
Rev. cuba. cir ; 61(4)dic. 2022.
Artigo em Espanhol | LILACS, MedCarib, CUMED | ID: biblio-1441528

Documentos relacionados

  1. Nimotuzumab combinado con un esquema de quimioterapia GEMOX en pacientes con cáncer pancreático avanzado
  2. Resultados con la utilización de prótesis en el cáncer de esófago y cardias
  3. Percepción de las asimetrías del mentón entre ortodoncistas, odontólogos especialistas, estudiantes y pacientes
  4. A Ferroptosis-Inducing Arsenene-Iridium Nanoplatform for Synergistic Immunotherapy in Pancreatic Cancer.
  5. [Investigation of Factors Related to Overall Survival in Patients Treated with Gemcitabine plus Paclitaxel(Albumin Suspension)for Advanced or Recurrent Pancreatic Cancer].
  6. Strategies for drug targeting in pancreatic cancer.
  7. In Vitro Tumor Cell-Binding Assay to Select High-Binding Antibody and Predict Therapy Response for Personalized <sup>64</sup>Cu-Intraperitoneal Radioimmunotherapy against Peritoneal Dissemination of Pancreatic Cancer: A Feasibility Study.
  8. Therapeutic efficacy of dose-reduced adjuvant chemotherapy with S-1 in patients with pancreatic cancer: a retrospective study.
  9. Systemic inflammation adversely affects response to anamorelin in patients with pancreatic cancer.
  10. Landmark Series: Neoadjuvant Treatment in Borderline Resectable Pancreatic Cancer.